PYPD
vs
S&P 500
PYPD
S&P 500
Over the past 12 months, PYPD has outperformed S&P 500, delivering a return of +33% compared to the S&P 500's +16% growth.
Stocks Performance
PYPD vs S&P 500
Performance Gap
PYPD vs S&P 500
Performance By Year
PYPD vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
PolyPid Ltd
Glance View
PolyPid Ltd. is a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
